Mablink Bioscience
Mablink Bioscience is an antibody-drug Conjugates founded in 2018.
B2X
Company Operating Status
Active
Country
Crunchbase URL
Email Address
contact@mablink.com?subject=Websitedirectmail
Founded Date
January 1, 2018
Headquarters
Investors
Latest Funding Round Date
October 1, 2022
Latest Funding Round Amount (USD)
30,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
39,600,000
Official Website
Find more companies like Mablink Bioscience
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.